Trial intelligence / Profile preview

Otitis media acuta in children with ventilation tubes

2012-001665-33Phase 4Terminated

Sponsor
Päijät-Häme Central Hospital
Start
Apr 2012
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4 trial of amoxicillin + clavulanate, levofloxacin and fluticasone in acute otitis media (AOM) and otorrhea (4 arms), sponsored by Päijät-Häme Central Hospital. Primary endpoint: Clinical resolution after 6 days of treatment. Started Apr 2012; status: terminated.

02

Drugs

amoxicillin + clavulanatelevofloxacinfluticasone
03

Conditions

acute otitis media (AOM)otorrhea

Beyond the preview

Go deeper on 2012-001665-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-001665-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call